Company News

cbdMD Starts Preclinical Human Study with the University of South Carolina

Exploring the effects of its proprietary cannabinoid blend and support product efficacy.

Author Image

By: Christine Esposito

Editor-in-Chief

Charlotte, NC-based cbdMD, Inc.—maker of cannabidiol (CBD) brands including topical products in skincare, personal care and body care—has started a preclinical human study with researchers at the University of South Carolina. The study will explore the effects of cbdMD’s proprietary broad spectrum cannabinoid blend on sleep, mood, and pain in healthy subjects to further support the efficacy of the company’s products.    The studies will also be measuring key safety markers in healthy humans to...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters